General obstetrics: A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study

@article{Shennan2006GeneralOA,
  title={General obstetrics: A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study},
  author={Andrew H. Shennan and Sarah Crawshaw and Annette L Briley and Jennifer Hawken and Paul T. Seed and Griff Jones and Lucilla Poston},
  journal={BJOG: An International Journal of Obstetrics \& Gynaecology},
  year={2006},
  volume={113}
}
Objective  To determine whether metronidazole reduces early preterm labour in asymptomatic women with positive vaginal fetal fibronectin (fFN) in the second trimester of pregnancy. 
View on Wiley
ncbi.nlm.nih.gov
68 Citations
Background Citations
4
Results Citations
1

68 Citations

Additional antibiotic use and preterm birth among bacteriuric and nonbacteriuric pregnant women

Clinical predictive factors for preterm birth in women with threatened preterm labour or preterm premature ruptured membranes?

Independent predictive factors of preterm delivery were evaluated using clinical data at hospitalisation by multivariate analysis to identify the most likely sources of maternal preterm birth complications.

Qualitative cervicovaginal fluid β-hCG versus cervicovaginal fluid fetal fibronectin assessment in prediction of preterm labor in asymptomatic high risk women

Qualitative β-hCG assessment in cervicovaginal fluid can be used as an alternative method to qualitative fFN assessment as it is a valid test, more available, and not expensive in prediction of PTL in asymptomatic high-risk patients.

Antibiotics for preventing preterm labour; An umbrella review

The result of this umbrella review does not supports the use of antibiotics during pregnancy except when there is a clear evidence of infection with extreme caution, regular follow ups and monitoring of the patient.

Goals and strategies for prevention of preterm birth: an obstetric perspective.

Bacterial Vaginosis Screening and Treatment in Pregnant Women.

An overview of BV is provided, the evidence regarding screening and treating BV in pregnant women is reviewed, and treatment recommendations for pregnant women who have symptomatic BV are summarized.

Pharmacological prevention of prematurity

Clinical trial of interconceptional antibiotics to prevent preterm birth: subgroup analyses and possible adverse antibiotic-microbial interaction.

Medical and surgical interventions for the prevention of preterm birth

This article reviews recent research findings, specifically addressing the following interventions: cerclage placement, detection and treatment of infections, progesterone administration, antibiotics in preterm labor and the use of tocolysis.

Emerging drug therapies for preventing spontaneous preterm labor and preterm birth

Although these three proactive, preventative approaches show promise, further research is needed to establish the best agent, the optimum gestational age at commencement and cessation, the ideal candidate patient to achieve a response and the long-term feto–maternal benefits and/or side effects.
...

References

SHOWING 1-10 OF 29 REFERENCES

Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial

Objective To ascertain whether metronidazole treatment of women with a heavy growth of Gardnerella vaginalis during mid‐pregnancy would reduce the risk of spontaneous preterm birth.

Fetal fibronectin test predicts delivery before 30 weeks of gestation in high risk women, but increases anxiety

Objective  To assess efficacy of cervico‐vaginal fetal fibronectin as a predictor of spontaneous preterm birth in a high risk antenatal population, and to evaluate the psychological impact of fetal…

Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery

To examine the potential value of routine measurement of cervical length in singleton pregnancies at 23 weeks of gestation in the prediction of the risk for early spontaneous preterm delivery.

Infection and prematurity and the role of preventive strategies.

The evidence that infection is causally linked to premature birth is critically examined, as is the relationship between urogenital tract infection/colonization with microorganisms and the risk of preterm birth.

Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study.

Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review

Cervicovaginal fetal fibronectin test is most accurate in predicting spontaneous preterm birth within 7-10 days of testing among women with symptoms of threatened pre term birth before advanced cervical dilatation.

Preterm labour--is bacterial vaginosis involved?

Metronidazole does not seem to reduce the prevalence of preterm labour when given for BV before 26 weeks' gestation, and analysis for maximum likelihood estimates for pre term labour identified only previous preterm Labour or midtrimester abortion as risk factors.

Randomized Clinical Trial of Metronidazole Plus Erythromycin to Prevent Spontaneous Preterm Delivery in Fetal Fibronectin–Positive Women

Antibiotic treatment of bacterial vaginosis in pregnancy: a meta-analysis.

The screening of pregnant women who have bacterial vaginosis and who have had a previous preterm delivery and treatment with an oral regimen of longer duration can be justified on the basis of current evidence.

Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis.